Company profile: Vdyne
1.1 - Company Overview
Company description
- Provider of proprietary transcatheter valve technology to treat tricuspid regurgitation via a unique side-delivery method, enabling treatment for a broader patient population; developing tricuspid replacement valve and repair technology.
Products and services
- Proprietary Valve Technology: A transcatheter device that treats tricuspid regurgitation using a unique side-delivery method, enabling therapy for a broader patient population
- Tricuspid Replacement Valve: A custom-engineered device developed to replace the tricuspid valve, contributing to Vdyne’s device portfolio for addressing tricuspid valve conditions
- Valve Repair Technology: A custom-engineered system focused on valve repair, complementing tricuspid replacement development to expand device-based treatment alternatives in the portfolio
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vdyne
Adient Medical
HQ: United States
Website
- Description: Provider of absorbable medical devices to prevent pulmonary embolism, including an Absorbable Vascular Filter that captures blood clots in the inferior vena cava for 12 weeks before dissolving into carbon dioxide and water.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adient Medical company profile →
PQ Bypass
HQ: United States
Website
- Description: Provider of minimally-invasive endovascular solutions advancing the treatment of long-segment peripheral artery disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PQ Bypass company profile →
InaVein
HQ: United States
Website
- Description: Provider of innovative products to treat the full spectrum of vein disorders. Founded in 2007, InaVein develops and commercializes technologies including the TRIVEX System, which uses direct visualization to completely remove varicose veins in a shorter period of time compared to conventional phlebectomy procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InaVein company profile →
Neovasc
HQ: Canada
Website
- Description: Provider of specialty cardiovascular medical devices and services, developing and manufacturing products for the cardiovascular device marketplace. Offers pericardial tissue processing and vascular product development, design, and manufacturing solutions to industry partners. Products include the Reducer device for treating refractory angina, supported by clinical studies evaluating its safety and effectiveness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neovasc company profile →
Tangent Medical
HQ: United States
Website
- Description: Provider of intravenous catheters and associated products to improve infusion therapy for patients and healthcare workers, based on proprietary technology exclusively licensed from the University of Michigan's Medical Innovation Center; development-stage medical device company founded in Ann Arbor in 2009.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tangent Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vdyne
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vdyne
2.2 - Growth funds investing in similar companies to Vdyne
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vdyne
4.2 - Public trading comparable groups for Vdyne
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →